Reckitt Benckiser Group (LON:RKT) Releases Quarterly Earnings Results

Reckitt Benckiser Group (LON:RKT – Get Free Report) posted its quarterly earnings results on Wednesday. The company reported GBX 101.40 earnings per share for the quarter, Digital Look Earnings reports. Reckitt Benckiser Group had a return on equity of 42.87% and a net margin of 21.09%.

Here are the key takeaways from Reckitt Benckiser Group’s conference call:

Get Reckitt Benckiser Group alerts:

• Q2 growth accelerated significantly, with Core Reckitt like-for-like revenue up 4.2% and volume growth reaching 2%, supported by balanced volume and price/mix contributions across all areas and categories.
• Emerging markets remained a key growth engine, delivering 9.4% like-for-like growth in Q2 and 12 consecutive quarters of double-digit growth in China, led by Dettol, VMS and continued innovation.
• Management reiterated 2026 guidance for 4%–5% Core Reckitt revenue growth and a 24.9%–25.6% adjusted operating margin, expecting stronger second-half performance from pricing, innovation, geographic mix and a more normal seasonal OTC cycle.
• Profitability remained under pressure: Core Reckitt and Mead Johnson gross margin fell 50 basis points to 60.5%, while adjusted EPS declined 9.7% to £1.521, primarily due to higher input costs and the loss of Essential Home earnings.
• Reckitt announced a further £500 million share buyback and increased its interim dividend by 5%, taking shareholder returns since the 2024 strategic plan announcement to more than £6 billion.

Reckitt Benckiser Group Trading Down 1.6%

Shares of Reckitt Benckiser Group stock opened at GBX 5,214 on Friday. The company’s fifty day simple moving average is GBX 4,835 and its 200-day simple moving average is GBX 5,277.92. The stock has a market capitalization of £33.11 billion, a PE ratio of 10.71, a P/E/G ratio of 1.10 and a beta of 0.25. Reckitt Benckiser Group has a 1-year low of GBX 3,866 and a 1-year high of GBX 6,522.92. The company has a debt-to-equity ratio of 179.24, a current ratio of 0.59 and a quick ratio of 0.46.

Insider Activity

In related news, insider Marybeth Hays bought 340 shares of the firm’s stock in a transaction that occurred on Monday, June 1st. The shares were bought at an average cost of GBX 4,585 per share, with a total value of £15,589. Also, insider Deepak Nath bought 257 shares of the stock in a transaction that occurred on Tuesday, June 23rd. The shares were bought at an average price of GBX 4,650 per share, for a total transaction of £11,950.50. Insiders acquired a total of 1,029 shares of company stock valued at $21,416,350 in the last 90 days. Company insiders own 0.44% of the company’s stock.

Wall Street Analyst Weigh In

RKT has been the subject of several research analyst reports. Jefferies Financial Group reiterated a “buy” rating and issued a GBX 5,900 price objective on shares of Reckitt Benckiser Group in a report on Wednesday. Royal Bank Of Canada restated a “sector perform” rating and set a GBX 6,200 target price on shares of Reckitt Benckiser Group in a research note on Wednesday. Citigroup dropped their price target on shares of Reckitt Benckiser Group from GBX 7,000 to GBX 6,200 and set a “buy” rating on the stock in a report on Thursday, April 23rd. Berenberg Bank decreased their price objective on shares of Reckitt Benckiser Group from GBX 7,000 to GBX 6,200 and set a “buy” rating for the company in a report on Friday, April 24th. Finally, Deutsche Bank Aktiengesellschaft restated a “hold” rating and set a GBX 5,400 price objective on shares of Reckitt Benckiser Group in a research report on Thursday. Four investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of GBX 6,242.86.

Get Our Latest Stock Report on Reckitt Benckiser Group

Reckitt Benckiser Group Company Profile

(Get Free Report)

At Reckitt, we protect, heal and nurture. We are the company behind some of the world’s best known and most trusted Health and Hygiene consumer brands.

Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.

We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.

At Reckitt, we’re all making a real difference to people all over the world, every day.

Read More

• Five stocks we like better than Reckitt Benckiser Group
• Chipotle Mexican Grill Stock Rallies as Q2 Results Top Fears, Guidance Rises
• L3Harris’ Record Backlog Makes Its Stock Sell-Off Look Overdone
• Quantum Earnings Could Decide Whether the Sector’s Sell-Off Has Gone Too Far
• Microsoft Just Flipped the AI Spending Narrative Overnight

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.